Search the Newsreel

Marcus & Millichap (NYSE:MMI) Shares Cross Above 200 Day Moving Average - Time to Sell?

Marcus & Millichap (NYSE:MMI) shares recently crossed above their 200-day moving average, reaching $32.24, despite a long-term average of $28.01. The company reported better-than-expected revenue of $171.47 million for the latest quarter, though adjusted earnings matched expectations at a loss of $0.08 per share. …

Marcus Corp (MCS) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Marcus Corp (MCS), highlighting its current valuation score, P/E ratio, and industry ranking. As of July 28, 2026, the company's valuation score is 6.46, placing it 108th out of 119 in the Hotels & Entertainment Services industry. …

Marcus & Millichap Brokers $12.5M Sale of Affordable Housing Community in Southern California

Marcus & Millichap has successfully brokered the $12.5 million sale of Guava Gardens, an 81-unit affordable seniors housing community in La Mesa, California. Los Angeles-based Positive Investments acquired the property, which was built in 1986 and reserves apartments for residents aged 62 and older. …

Marcus & Millichap Brokers $12.3M Sale of 46-Unit Property in Anaheim, California

Marcus & Millichap has brokered the $12.3 million sale of Villa Samoa, a 46-unit apartment community in Anaheim, California. The property, built in 1964, was sold by an undisclosed seller, with the buyer also remaining unnamed. The buyer intends to renovate the property, which …

Arcus Biosciences Inc (RCUS) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Arcus Biosciences Inc (RCUS), noting its current valuation score is 7.45, ranking 222 out of 386 in the Biotechnology & Medical Research industry. The company's P/E ratio is -8.78. Important financial data such as P/B, P/S, and …

Circus Aktie: Prognose auf 5,2 Millionen gekürzt

Marcus & Millichap Inc (MMI) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Marcus & Millichap Inc (MMI), detailing its price momentum, support and resistance levels, and various technical indicators and moving averages. While the stock's price is currently trading within a range suitable for swing trading, the overall signal …

MCS|Marcus Corp|Price:24.450|Chg%:+0.630

This article provides a comprehensive financial overview of Marcus Corp (MCS), detailing its stock performance, key financial indicators, and recent earnings data. It includes breakdowns of the company's income statement, balance sheet, and cash flow statement, along with quarterly and annual performance metrics. The …

Three new Arcus employees receive options and 6,300 restricted stock units

Arcus Biosciences (NYSE: RCUS) announced that its Compensation Committee granted three new employees options to purchase a total of 12,600 shares of common stock at an exercise price of $29.73 per share, along with restricted stock units for 6,300 shares. These equity awards were …

Marcus & Millichap Inc (MMI) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Marcus & Millichap Inc (MMI), identifying major shareholders like Phoenix Investment Adviser LLC and BlackRock Institutional Trust Company, N.A., and categorizing shareholders by type. It also provides institutional shareholding trends over recent quarters, including the number of …

Marcus & Millichap Arranges Sale of 13,079-Square-Foot Retail Property in Metro Dallas

Marcus & Millichap has facilitated the sale of India Bazaar Plaza, a 13,079-square-foot retail property in Little Elm, Texas, north of Dallas. The center, built in 2018, is fully leased to India Bazaar and Shahnaz Salon & Threading. Scott Abeel and Philip Levy represented …

Marcus & Millichap Brokers $9.9M Sale of Cincinnati Medical Office Building

Marcus & Millichap has brokered the $9.9 million sale of a 26,107-square-foot medical office building in Cincinnati. The property, constructed in 2008 and located at 8099 Cornell Road, is fully leased to Ortho Alliance MSO LLC/Beacon Orthopedics & Sports Medicine Ltd. Frank Roti, Thomas …

Is Marcus & Millichap (MMI) Quietly Repositioning Its Capital Markets Strategy With Demadis Hire?

Marcus & Millichap's IPA Capital Markets division recently hired Ryan Demadis as managing director in Boston, bringing significant debt and equity financing experience. This hire aligns with the company's strategy to deepen its capital markets capabilities, particularly in industrial and multifamily properties, to reinforce …

Is Marcus & Millichap (MMI) Above Fair Value On Its Boston Financing Hire?

Marcus & Millichap (MMI) has garnered attention after hiring a new managing director for its IPA Capital Markets division in Boston, strengthening its focus on industrial and multifamily property financing in the Northeast. Despite recent share price momentum, the stock is trading above the …

Arcus Biosciences Inc (RCUS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Arcus Biosciences Inc (RCUS), focusing on its business segments. For the fiscal year 2025, the company reported $221.00 million from license and development services, accounting for 89.47% of its revenue, and $26.00 million from collaboration, making up …

Marcus & Millichap (MMI) Appoints Ryan Demadis To Lead IPA Capital Markets In Boston

Marcus & Millichap (NYSE:MMI) has appointed Ryan Demadis as Managing Director of IPA Capital Markets in Boston, where he will focus on industrial and multifamily real estate financing. This strategic hire aims to enhance the firm's presence in a competitive capital markets segment, particularly …

Marcus & Millichap Brokers Sale of Broussard Industrial Facility Leased to Drilling Tools International

Marcus & Millichap announced the sale of a 35,840-square-foot industrial property in Broussard, Louisiana, leased to Drilling Tools International, to a real estate investment trust (REIT). The transaction, valued at over $130 per square foot, highlights strong investor interest in Gulf Coast energy-service industrial …

Marcus Corp (MCS) Income Statement

This article provides the quarterly and annual income statements for Marcus Corp (MCS), detailing key financial metrics such as total revenue, cost of revenue, operating expenses, operating profit, net income, and earnings per share over several fiscal quarters and years. It also includes an …

Arcus Biosciences Inc (RCUS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Arcus Biosciences Inc (RCUS), identifying its major shareholders and institutional holdings. It provides a breakdown of ownership by entity type and lists changes in institutional shareholding over several quarters, highlighting key investors like Gilead Sciences, Inc. and …

Marcus & Millichap Facilitate Sale of a 41-Unit Orange County Multifamily Property

Marcus & Millichap announced the sale of Sundance West Apartment Homes, a 41-unit multifamily property in Costa Mesa, California, for $16.9 million. The property, built in 1962, offers a mix of two- and three-bedroom units and was sold by a local family to a …

Price to sales forward of Arcus Biosciences, Inc. – NYSE:RCUS

The article provides a financial metric, "Price to sales forward," for Arcus Biosciences, Inc. (NYSE:RCUS) on TradingView. It appears to be a stub or a section of a larger financial data page, as the actual value and period for the metric are not displayed …

Marcus Corp (MCS) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Marcus Corp (MCS), detailing its current earnings forecast score, analyst ratings, and price targets. It includes peer comparisons and answers frequently asked questions regarding expected revenue, price targets, and past EPS performance. The data indicates a generally …

Marcus & Millichap Inc (MMI) Valuation: PE, PB & Fair Value Analysis

Marcus & Millichap Inc (MMI) has a current valuation score of 9.03, ranking 12th out of 47 in the Real Estate Operations industry. Its P/E ratio is -1832.33, marking a significant decrease from its recent high but slightly above its recent low. The company …

3 Reasons to Avoid MMI and 1 Stock to Buy Instead

3 Reasons to Avoid MMI and 1 Stock to Buy Instead Marcus & Millichap trades at $29.92 and has moved in lockstep with the market. Its shares have returned 11.5% over the last six months while the S&P 500 has gained 7.9%. Is now …

Marcus & Millichap Arranges $12.5M Sale of 81-Unit Multifamily Property in La Mesa California

Marcus & Millichap announced the sale of a senior affordable 81-unit multifamily property at 5035-49 Guava Ave. in La Mesa, California for $12.5 million. The transaction highlights continued demand for well-maintained affordable senior housing in San Diego County, reflecting the property's unique perpetual affordability …

Does Arcus Biosciences’ (RCUS) AVEO Tie-Up Hint At A New Combo-First RCC Strategy?

Arcus Biosciences and AVEO Oncology have partnered for a clinical supply agreement to test casdatifan with tivozanib in a new ARC-20 study cohort for advanced clear cell renal cell carcinoma patients. This collaboration expands Arcus's oncology pipeline, particularly for casdatifan, but the company still …

Marcus & Millichap Brokers Sale of 132-Unit Multifamily Property in the Miracle Mile Neighborhood of Los Angeles

Marcus & Millichap announced the sale of Palm Court Apartments, a 132-unit multifamily property in Los Angeles's Miracle Mile neighborhood, for $51.25 million. The property offers convenient access to major attractions, public transport, and employment centers. Built in 1988, it features a mix of …

Marcus & Millichap Releases Indianapolis Multifamily Report for Q2 2026

Marcus & Millichap has released its Q2 2026 Indianapolis Multifamily report, highlighting the market's stability and growth potential. The report anticipates an employment rebound in 2026, with an expected 10,000 new jobs, leading to improved market fundamentals, including a decrease in vacancy and a …

D-BOX Technologies, Inc. to Launch Motion Seating in Multiple Auditoriums at Marcus Theatres Locations in Oakdale, Minn. and Orland Park, Ill.

D-BOX Technologies Inc. is partnering with Marcus Theatres to install its premium haptic and motion seating in six auditoriums across two locations: Oakdale Cinema in Oakdale, Minnesota, and Orland Park Cinema in Orland Park, Illinois. This collaboration marks the first time D-BOX technology will …

MMI|Marcus & Millichap Inc|Price:29.915|Chg%:-0.355

This article provides a company profile for Marcus & Millichap Inc (MMI), a real estate services firm specializing in commercial real estate investment sales, financing, and advisory services. It details the company's offerings, key information such as its IPO date and CEO, and lists …

Knott David M Jr Trims Stake in Arcus Biosciences, Inc. $RCUS

Marcus & Millichap clients to get tax-deferred exchange platform

Marcus & Millichap has partnered with Deferred, a technology-powered qualified intermediary, to offer its clients enhanced 1031 exchange solutions. This collaboration aims to provide streamlined access to tools that help real estate investors defer capital gains taxes, preserve equity, and efficiently reinvest. The partnership …

Marcus & Millichap Inc (M6M) Q1 2024 Earnings Report - Results, Call & Slides

Marcus & Millichap Inc (M6M) reported its Q1 2024 earnings, beating analyst expectations with an actual EPS of -€0.23 against a consensus of -€0.25, and revenue of €113.07M exceeding the expected €111.67M. Despite beating estimates, the company experienced a year-over-year revenue decline of 16.60%. …

Press Release: Marcus & Millichap, Inc. to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Marcus & Millichap, Inc. (NYSE: MMI) is scheduled to release its second-quarter 2026 financial results on Thursday, August 6, 2026, after the close of market. Following the release, the company will host a conference call and webcast at 2:00 p.m. Pacific Time (5:00 p.m. …

Marcus & Millichap Schedules Aug. 6 Webcast on Q2 Results

Marcus & Millichap, Inc. (NYSE: MMI) announced it will report its Q2 2026 financial results on Thursday, August 6, 2026, before market open. The company will host a webcast and conference call at 10:30 a.m. Eastern Time to discuss the results, featuring President and …

Marcus (MCS) Expected to Release Quarterly Earnings on Thursday